Clinical Research On The Treatment Of Dyslipidemia With Compound Jiangzhi Huoxue Yin

Objective:To study the regulatory effect of compound Jiangzhi Huoxue Yin on blood lipids in patients with primary dyslipidemia.Methods:Sixty patients with primary dyslipidemia were randomly divided into two groups.The treated group was treated with Compound Jiangzhi Huoxue Yin 1 packet twice a day,and the control group was treated with Zhibituo capsule by oral taking 2 tablets twice a day.The therapeutic course for both groups was 6 weeks.The effect in regulating blood lipids in patients was observed.Results:Clinical curative effect and symptomatic gross curative effect of the treated group was superior to the control group(P＜0.05).At the side of the regulatory effect on blood lipids,both of the two groups could regulate total cholesterol(TC),triglyceride(TG),low density lipoprotein cholesterol (LDL-C),high density lipoprotein cholesterol(HDL-C) obviously(P＜0.01).As compared the effect between the two groups,the lowering of TC,LDL-C and the elevating of HDL-C in the treatment group had obvious statistical discrepancy to the control group,but the statistical analysis showed that the two groups didn't have obvious discrepancy on elevating the TG(P＞0.05).At the side of the clinical symptomatic curative effect,the two groups are both better than prior treatment on vague pain of chest and hypochondrium,anorexia,numbness on limbs and cerebaria (P＜0.01).As compared the clinical symptomatic curative effect between the two groups,the treatment group can improvement the symptom obviously than the control group,and the statistical analysis showed they had obvious discrepancy(P＜0.01).Conclusion:Jiangzhi Huoxue Yin had definited regulatory effect on the blood lipids and clinical symptom in patient s with dyslipidemia.